Drug intelligence / Profile preview

medicago sativa top

Development stage: Unknown
Administration: Oral

Overview

*Medicago sativa* top, commonly known as alfalfa, refers to the aerial parts of the plant, including the leaves and stems. It is classified as an experimental biologic in the DrugBank database (DB16546). While alfalfa is widely recognized as a dietary supplement and forage crop, its pharmaceutical development involves investigating its bioactive constituents, such as saponins, flavonoids, and phytoestrogens. These compounds are traditionally associated with potential lipid-lowering and endocrine-modulating effects, although no specific therapeutic indication or biological target has been formally established in clinical trials for this specific preparation.

Other names: Alfalfa leaf/stemAlfalfa topAlfalfa, topMedicago sativa herbMedicago sativa leaf/stem

Targets

ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on medicago sativa top.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on medicago sativa top.

Explore the full profile